Literature DB >> 8993331

Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro.

S P Lee1, J Xiao, J R Knutson, M S Lewis, M K Han.   

Abstract

It has been recently demonstrated that the Mg(2+)-dependent 3'-processing activity of purified human immunodeficiency virus type-1 (HIV-1) integrase is stimulated by the addition of exogenous Zn2+ [Lee, S. P., & Han, M. K. (1996) Biochemistry 35, 3837-3844]. This activation was hypothesized to result from integrase self-association. In this report, we examine the Zn2+ content of purified HIV-1 integrase by atomic absorption spectroscopy and by application of a thiol modification reagent, p-(hydroxymercuri)benzenesulfonate, with a metallochromic indicator, 4-(2-pyridylazo)resorcinol. We find that the Zn2+ content of HIV-1 integrase varies from 0.1 to 0.92 equiv of Zn2+ per monomer depending on the conditions of protein purification. In vitro activity assays, time-resolved fluorescence emission anisotropy, and gel filtration chromatographic analyses all indicate that EDTA yields an apoprotein which is predominantly monomeric and less active with Mg2+. Further, sedimentation equilibrium studies reveal that reconstitution of the apoprotein with Zn2+ results in a monomer-tetramer-octamer transition. These results suggest that Zn2+ promotes a conformation with enhanced oligomerization and thereby stimulates Mg(2+)-dependent 3'-processing. This may also imply that multimers larger than dimers (tetramers and possibly octamers) are required for in vitro activity of integrase in the presence of Zn2+ and Mg2+. It should be noted, however, that the content of Zn2+ did not significantly affect the 3'-processing and strand transfer reactions with Mn2+ in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993331     DOI: 10.1021/bi961849o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  71 in total

1.  Sustained release of human growth hormone from PLGA solution depots.

Authors:  K J Brodbeck; S Pushpala; A J McHugh
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  HIV-1 integrase catalytic core: molecular dynamics and simulated fluorescence decays.

Authors:  C Laboulais; E Deprez; H Leh; J F Mouscadet; J C Brochon; M Le Bret
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

3.  Molecular dynamics studies on the HIV-1 integrase catalytic domain.

Authors:  R D Lins; J M Briggs; T P Straatsma; H A Carlson; J Greenwald; S Choe; J A McCammon
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

Review 4.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

5.  Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration.

Authors:  M L Holmes-Son; S A Chow
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.

Authors:  Charles W Dobard; Marisa S Briones; Samson A Chow
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

7.  Functional analysis of N-terminal residues of ty1 integrase.

Authors:  Sharon P Moore; David J Garfinkel
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

8.  Architecture and assembly of HIV integrase multimers in the absence of DNA substrates.

Authors:  Ravi Shankar Bojja; Mark D Andrake; George Merkel; Steven Weigand; Roland L Dunbrack; Anna Marie Skalka
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

9.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

10.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.